Table 3.
Proportion of patients with incomplete follow-up.
| Africa | Thailand | Overall | |
| Unadjusted Analysis | 7619 | 7790 | 15,409 |
| Interrupted follow-upa | 360 (4.7%) | 1117 (14.3%) | 1477 (9.6%) |
| Non-falciparum new infections | 40 (0.5%) | 1120 (14.4%) | 1160 (7.5%) |
| Overall | 400 (5.3%) | 2237 (28.7%) | 2637 (17.1%) |
| Adjusted Analysisb | 7619 | 5813 | 13,432 |
| Interrupted follow-upa | 360 (4.7%) | 673 (11.6%) | 1033 (7.7%) |
| Non-falciparum new infections | 40 (0.5%) | 1023 (17.6%) | 1063 (7.9%) |
| P. falciparum new infections | 1864 (24.5%) | 323 (5.6%) | 2187 (16.3%) |
| Unsuccessful genotyping | 107 (1.4%) | 99 (1.7%) | 206 (1.5%) |
| Overall | 2371 (31.1%) | 2118 (36.4%) | 4489 (33.4%) |
a Includes all patients with interrupted follow-up (outcomes 13–20 in table 1)
b Excludes 1977 Thai patients (from 5 studies with 8 treatment arms) in which genotyping was not attempted